หัวข้อนี้ 6/10 และได้คะแนน 5/6 ใน DB2020 Best regulatory performance: India Kazakhstan and Malta 2.2 Extent of ownership and control (การเป็น https://www.sec.or.th/TH/Documents/AboutUs/Protecting-Minority

, and 1,722.70 million baht for year 2016, 2017, and 2018 respectively. As can be seen, the revenue from sale increased continuously every year. In the year 2018, increased orders and the market expansion

by 275.91% to Baht 221.90 million as compared to 2017 net profit in the amount of Baht 59.03 million. The aforementioned changes in the financial performance are summarized as seen in the below table

decreased by 45.02% to Baht 121.99 million as compared to 2018 net profit in the amount of Baht 221.90 million. The aforementioned changes in the financial performance are summarized as seen in the below

71.44 70.09 Proportion of cost of administrative expenses/revenue of medical treatment 12.54 13.13 It can be seen that the proportion of cost of medical treatment and administrative expenses / revenue of

by 23.8% to Baht 59.03 million as compared to 2016 net profit in the amount of Baht 77.47 million. The aforementioned changes in the financial performance are summarized as seen in the below table

medical treatment 67.53 69.02 Proportion of cost of administrative expenses/revenue of medical treatment 12.72 12.17 It can be seen that the proportion of cost of medical treatment and administrative

or 1.08% from the level seen as of December 31, 2018. The debt to equity ratio stood at 0.12 times and the current ratio was at 2.36 times. - The shareholders’ equity stood at 1,524.12 million baht

/ revenue of medical treatment 68.10 71.46 Proportion of cost of administrative expenses/revenue of medical treatment 17.45 12.54 It can be seen that the proportion of cost of medical treatment and

(net) 12.52 20.87 Proportion of cost of medical treatment / revenue of medical treatment 65.01 65.22 Proportion of cost of administrative expenses/revenue of medical treatment 11.53 11.57 It can be seen